A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.
Authors: Amonoo HL; 1Department of Supportive Oncology, Dana-Farber Cancer Institute, Boston, MA.; 2Department of Psychiatry, Mass General Brigham, Boston, MA.; 3Harvard Medical School, Boston, MA., Newcomb R; 3Harvard Medical School, Boston, MA.; 4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Psenka R; 4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.; 5College of Medicine, Medical University of South Carolina, Charleston, SC., Samarakoon U; 4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Greer JA; 2Department of Psychiatry, Mass General Brigham, Boston, MA.; 3Harvard Medical School, Boston, MA., Nelson AM; 2Department of Psychiatry, Mass General Brigham, Boston, MA.; 3Harvard Medical School, Boston, MA., Barata A; 2Department of Psychiatry, Mass General Brigham, Boston, MA.; 3Harvard Medical School, Boston, MA., Traeger L; 6Department of Psychology, University of Miami, Miami, FL., Farnam EJ; 4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Pepper J; 4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Caruso E; 4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Larizza IS; 2Department of Psychiatry, Mass General Brigham, Boston, MA., Keane EP; 2Department of Psychiatry, Mass General Brigham, Boston, MA., Desai S; 7Novobeing, Boston, MA., Vassev N; 7Novobeing, Boston, MA., Rabideau DJ; 3Harvard Medical School, Boston, MA.; 8MGH Department of Biostatistics, Massachusetts General Hospital, Boston, MA., Horick N; 8MGH Department of Biostatistics, Massachusetts General Hospital, Boston, MA., DeFilipp Z; 3Harvard Medical School, Boston, MA.; 4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Chen YB; 3Harvard Medical School, Boston, MA.; 4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., Temel JS; 3Harvard Medical School, Boston, MA.; 4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA., El-Jawahri A; 3Harvard Medical School, Boston, MA.; 4Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
Source: Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2026 Jun 30, pp. 1-9. Date of Electronic Publication: 2026 Jun 30.
Publication Type: Journal Article
Journal Info: Publisher: Harborside Press Country of Publication: United States NLM ID: 101162515 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1540-1413 (Electronic) Linking ISSN: 15401405 NLM ISO Abbreviation: J Natl Compr Canc Netw Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first